Uniting industry experts dedicated to implementing digital biomarkers in Neurodegenerative, Movement and Neuropsychiatric Disorders clinical trials, the Digital Biomarkers & Clinical Measures in Neurology Summit is the definitive industry forum sharing cross-industry insight to transform clinical development with digital data.

From integrating wearable technologies, smartphone apps, and speech-based digital biomarkers into remote clinical research to elucidating pathways to clinical validation to establish therapeutic efficacy, join industry experts from Merck, Janssen, GSK, Sanofi, Novartis, Takeda, Eli Lilly & Company, Mitsubishi Tanabe Pharma Holdings America and many more to improve patient retention and establish efficacy with richer datasets.